Characterization of phosphate transport in rat vascular smooth muscle cells - Implications for vascular calcification

被引:104
作者
Villa-Bellosta, Ricardo
Bogaert, Yolanda E.
Levi, Moshe
Sorribas, Victor
机构
[1] Univ Zaragoza, Mol Toxicol Lab, Fac Vet, E-50013 Zaragoza, Spain
[2] Denver VAMC, Dept Med, Div Renal Dis & Hypertens, Denver, CO USA
[3] Denver VAMC, Dept Physiol & Biophys, Div Renal Dis & Hypertens, Denver, CO USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
关键词
vascular calcification; phosphate transport; VSMC; Pit1; Pit2;
D O I
10.1161/ATVBAHA.106.132266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Hyperphosphatemia and inorganic phosphate (Pi) transport by vascular smooth muscle cells (VSMCs) have been implicated in the pathogenesis of vascular calcification. The aim of this work has been to characterize Pi transport in VSMCs. Methods and Results - Primary cultures of VSMCs express both high affinity Na-dependent and Na-independent components of Pi transport. Under physiological conditions both transport systems are saturated, show similar activity, and are inhibited by increasing pH. The Na-dependent transport is also weakly inhibited by phosphonoformic acid (PFA) (3.9 mmol/L IC50 at 0.05 mmol/L Pi). Real-time polymerase chain reaction shows that Pit1 and Pit2 are expressed to the same degree, and no other Pi transporters are significantly expressed. When expressed in Xenopus oocytes they are strictly Na-dependent, with high affinities for Pi, and are inhibited by increasing pH, but only weakly inhibited by PFA. We have used RNA interference to demonstrate that Pit1 and Pit2 are the transporters responsible for Na-dependent Pi transport in VSMCs. Conclusions - Taken together these novel findings suggest new roles of Pi transport in the pathogenesis of VC and have implications as potential future clinical targets.
引用
收藏
页码:1030 / 1036
页数:7
相关论文
共 30 条
[1]  
Abedin M, 2004, ARTERIOSCLER THROMB, V24, P1
[2]  
Alfrey A C, 1978, Adv Exp Med Biol, V103, P187
[3]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[4]  
BOTTGER P, IN PRESS AM J PHYSL
[5]   The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells [J].
Chen, N. X. ;
Duan, D. ;
O'Neill, K. D. ;
Wolisi, G. O. ;
Koczman, J. J. ;
LaClair, R. ;
Moe, S. M. .
KIDNEY INTERNATIONAL, 2006, 70 (06) :1046-1053
[6]   High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells [J].
Chen, Neal X. ;
Duan, Danxia ;
O'Neill, Kalisha D. ;
Moe, Sharon M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) :3435-3442
[7]   Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells [J].
Chen, NX ;
O'Neill, KD ;
Duan, D ;
Moe, SM .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1724-1731
[8]   The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors [J].
Collins, JF ;
Bai, LQ ;
Ghishan, FK .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :647-652
[9]   Molecular determinants of pH sensitivity of the type IIa Na/Pi cotransporter [J].
de la Horra, C ;
Hernando, N ;
Lambert, G ;
Forster, I ;
Biber, J ;
Murer, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6284-6287
[10]   Vascular calcification and inorganic phosphate [J].
Giachelli, CM ;
Jono, S ;
Shioi, A ;
Nishizawa, Y ;
Mori, K ;
Morii, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S34-S37